Pharmacokinetic-toxicodynamic relationships of adriamycin in rat: Prediction of butylated hydroxyanisole-mediated reduction in anthracycline cardiotoxicity

Journal of Pharmacy and Pharmacology

Volumn 48, Issue 12, 1996, Pages 1264-1269

  Vora, Jayesh ^a,b   Boroujerdi, Mehdi ^a  

^a NORTHEASTERN UNIVERSITY   (United States)

^b BUTLER UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ANTIOXIDANT; BUTYLATED HYDROXYANISOLE; CARBON 14; CREATINE KINASE; DOXORUBICIN;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; CARDIOTOXICITY; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DRUG BLOOD LEVEL; DRUG DISPOSITION; DRUG URINE LEVEL; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY CLEARANCE; MALE; NONHUMAN; PREDICTION; RAT;

EID: 0030478388     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.2042-7158.1996.tb03934.x     Document Type: Article

References (20)

1. Bapat, N., Boroujerdi, M. (1993) Effect of colloidal carriers on the disposition and tissue uptake of doxorubicin. Part I. Conjugation with oxidized dextran particles. Drug. Dev. Ind. Pharm. 10: 2651-2665
2. Benson, I. J., Batzinger, R. P., Ou, S. Y. L., Bueding, E., Cha, Y. N., Talalay, P. (1978) Elevation of hepatic glutathione-S-transferase activities and protection against mutagenic metabolites of benzo(a)pyrene by dietary antioxidants. Cancer Res. 38: 4486-4495
3. Billingham, M. E., Bristow, M. R. (1984) Evaluation of anthracycline cardiotoxicity: predictive ability and functional correlation of endomyocardial biopsy. Cancer Treat. Symp. 3: 71-76
4. Calabresi, P., Schein, P. S., Rosenberg, S. A. (1985) Medical Oncology, Macmillan Publishing, New York
5. Carrio, I., Estorch, M., Berna, L., Germa, J. R., Alonso, C., Ojeda, B., de Andres, L., Lopez-Pousa, A., Marinez-Duncker, C., Torres, G. (1991) Assessment of anthracycline-induced myocardial damage by quantitative indium-111 myosin-specific monoclonal antibody studies. Eur. J. Nucl. Med. 18: 806-812
6. Demkowicz-Dobrazanski, K. K., Henning, E. E., Juskiewicz-Skiba, M., Peirkarski, L. (1984) Modifications of microsomal and nuclear fractions of butylated hydroxyanisole and its effect on benzo(a)pyrene metabolites binding to macromolecules. Neoplasma 31: 423-430
7. Doroshow, J. H., Locker, G. Y., Iftim, I., Myers, C. E. (1982) Prevention of doxorubicin cardiac toxicity in the mouse by N-acetylcysteine. J. Clin. Inv. 68: 1053-1064
8. Gibaldi, M., Perrier, D. (1982) Pharmacokinetics, Marcel Dekker, New York
9. 111in monoclonal antimyosin Fab in detecting doxorubicin cardiotoxicity in rats. Circulation 86: 1965-1972
10. Hortobagyi, G. N., Frye, D., Buzdar, A. U., Ewer, M. S., Fraschini, G., Hug, V., Ames, F., Montagne, E., Carrasco, C. H., MacKay, B., Benjamin, R. S. (1982) Decreased cardiac toxicity of doxorubicin administered by continuous intravenous infusion in combination chemotherapy for metastatic breast carcinoma. Cancer 63: 288-297
11. Lown, J. W., Chen, H. H., Plambeck, J. A., Acton, E. M. (1982) Further studies on the generation of reactive oxygen species from activated anthracyclines and the relationships to cytotoxic action and cardiotoxic effects. Biochem. Pharmacol. 31: 575-581
12. Mason, J. W., Bristow, M. R., Billingham, M. E., Daniels, J. R. (1978) Invasive and noninvasive methods to assessing adriamycin cardiotoxic effects in man: superiority of histopathologic assessment using endomyocardial biopsy. Cancer Treat. Rep. 62: 857-863
13. McLaughlin, W. J., Boroujerdi, M. (1987) BHA (2(3)-tert-butyl-4-hydroxyanisole)-mediated modulation of acetaminophen phase II metabolism in vivo in Fisher 344 rats. Res. Commun. Chem. Pathol. Pharmacol. 56: 321-333
14. Mimnaugh, E. G., Siddik, Z. H., Drew, P., Sikic, B. I., Gram, T. (1979) The effects of alpha-tocopherol on the toxicity, disposition, and metabolism of adriamycin in mice. Toxicol. Appl. Pharmacol. 49: 119-126
15. Powis, G., Hacker, M. P. (1991) The toxicity of anticancer drugs, Pergamon Press, New York
16. Preus, M., Bhargava, A. S., Khater, A. E. R., Gunzel, P. (1988) Diagnostic value of serum creatine kinase and lactate dehydrogenase isozyme determinations for monitoring early cardiac damage in rats. Toxicol. Lett. 42: 225-233
17. Sharkey, S. W., Muarkami, M. M., Smith, S. A., Apple, F. S. (1991) Canine myocardial creatine kinase isozymes after chronic coronary artery occlusion. Circulation 84: 333-340
18. Von Hoff, D. D., Rozencweig, M., Layard, M. (1979) Factors for adriamycin-induced congestive heart failure. Ann. Intern. Med. 91: 710-717
19. Vora, J., Boroujerdi, M. (1995) Enhanced aqueous solubility of phenolic antioxidants using modified beta-cyclodextrins. Drug Develop. Ind. Pharm. 21: 495-502
20. Vora, J., Khaw, B.-A., Narula, J., Boroujerdi, M. (1996) Protective effect of butylated hydroxyanisole on adriamycin induced cardiotoxicity. J. Pharm. Pharmacol. 48: 940-944